Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.

about

Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety.

P2860

Q50101377-032614ED-BB01-4591-A88B-04349D6B8E50 Q52575674-29E92487-30B5-4C02-BEB4-C1F6150624DF

P2860

Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q47678193

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Biomarker-based strategy for e ...... a randomized controlled trial.

@en

Biomarker-based strategy for e ...... a randomized controlled trial.

@nl

type

Item

label

Biomarker-based strategy for e ...... a randomized controlled trial.

@en

Biomarker-based strategy for e ...... a randomized controlled trial.

@nl

prefLabel

Biomarker-based strategy for e ...... a randomized controlled trial.

@en

Biomarker-based strategy for e ...... a randomized controlled trial.

@nl

P1476

Biomarker-based strategy for e ...... a randomized controlled trial

@en

P2093

Benoit Dervaux

http://www.w3.org/2001/XMLSchema#string

Julien Poissy

http://www.w3.org/2001/XMLSchema#string

S-TAFE study group

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive care medicine research agenda on invasive fungal infection in critically ill patients.

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study

Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.

Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.

P2888

s00134-017-4932-8

P304

1668-1677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00134-017-4932-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28936678

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.

about

P2860

P2860

Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921